Piciocchi A

30PUBLICATIONS
155CO-AUTHORS
NanomedicinePredictive and prognostic markersHaematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Jun 18, 2026
Vaccination and Antiviral Combination Improves Resolution Time of COVID-19 Infection in Treated Multiple Myeloma: A Retrospective Study.

|Mar 06, 2026
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia.

Niccolò Bartalucci, Francesco Mannelli, Danilo Tarantino

|Mar 05, 2026
Validation of ICC hierarchical classification in secondary AML.

Enrico Attardi, Marta Cipriani, Luca Guarnera

|May 07, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.

Anna Sicuranza, Massimo Breccia, Francesco Iuliano

|May 05, 2025
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis.

Corrado Girmenia, Patrizia Chiusolo, Giovanni Marsili

Pageof 5

Frequent Collaborators

9 joint publications

Adriano Venditti

9 joint publications

Marco Vignetti

9 joint publications

Maria Teresa Voso

5 joint publications

Monica Bocchia